You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

August 12, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Safety of new drugs questioned by researchers

Physicians and patients should avoid new drugs unless they are truly breakthrough drugs, according to a study. » What's happened since PDUFA was passed?

Pharmacist intervention improves medication adherence: Study

Community pharmacists can have a significant role in improving an entire patient population’s medication adherence, and its overall health, according to a study. » How to improve adherence for 5 medication classes

EDITOR'S PICK

Drug Overview: Tasimelteon (Hetlioz)

It is estimated that up to 100,000 people in the United States have non-24-hour-sleep-wake disorder (N24HSWS). Hetlioz (tasimelteon) is a melatonin receptor agonist, similar to Rozerem (ramelteon) that was approved by FDA in January 2014 for the treatment of N24HSWS caused by a completely blind person’s inability to regulate their internal clock. » Full article

Continuing Education

MTM essentials for atrial fibrillation and drug-induced arrhythmia management

This month's article is the seventh in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review current clinical practice guidelines related to atrial fibrillation.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT08-KTF27.


Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

 

Related Articles

FDA drug approvals-August 2014

Study: Lifestyle factors play a role in statin med adherence

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group